Pasar al contenido principal

MODELANDO EL PRECANCER EN LA DEFICIENCIA REPARADORA DE APAREAMIENTOS ERRONEOS GERMINAL PARA UN SEGUIMIENTO PERSONALIZADO BASADO EN LA RESPUESTA IMMUNE

PID2019-111254RB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2019
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario FUNDACIO INSTITUT D INVESTIGACIO BIOMEDICA DE BELLVITGE (IDIBELL)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 7
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Tumor analysis of MMR genes in Lynch-like syndrome, Challenges associated with results interpretation

  • Rofes, Paula|||0000-0001-6045-7879
  • Dueñas Cid, Nuria|||0000-0001-6624-3265
  • Del Valle, Jesús|||0000-0003-3607-7045
  • Navarro, Matilde
  • Balmaña Gelpí, Judith|||0000-0002-0762-6415
  • Ramon y Cajal, Teresa|||0000-0003-3490-3585
  • Tuset, Noemí
  • Castillo, Carmen
  • González, Sara
  • Brunet, Joan|||0000-0003-1945-3512
  • Capella, Gabriel|||0000-0002-4669-7320
  • Lázaro García, Conxi|||0000-0002-7198-5906
  • Pineda, Marta|||0000-0002-5403-5845
Up to 70% of suspected Lynch syndrome patients harboring MMR deficient tumors lack identifiable germline pathogenic variants in MMR genes, being referred to as Lynch-like syndrome (LLS). Previous studies have reported biallelic somatic MMR inactivation in a variable range of LLS-associated tumors. Moreover, translating tumor testing results into patient management remains controversial. Our aim is to assess the challenges associated with the implementation of tumoral MMR gene testing in routine workflows. Methods: Here, we present the clinical characterization of 229 LLS patients. MMR gene testing was performed in 39 available tumors, and results were analyzed using two variant allele frequency (VAF) thresholds (≥5% and ≥10%). Results and Discussion: More biallelic somatic events were identified at VAF ≥ 5% than ≥10% (35.9% vs. 25.6%), although the rate of nonconcordant results regarding immunohistochemical pattern increased (30.8% vs. 20.5%). Interpretation difficulties question the current utility of the identification of MMR somatic hits in the diagnostic algorithm of suspected LS cases.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Altered chromatin landscape and 3D interactions associated with primary constitutional MLH1 epimutations

  • Climent-Cantó, Paula
  • Subirana-Granés, Marc
  • Ramos-Rodríguez, Mireia
  • Dámaso, Estela
  • Marín, Fátima
  • Vara, Covadonga
  • Pérez-González, Beatriz
  • Raurell Vila, Helena
  • Munté, Elisabet
  • Soto, José Luis
  • Alonso, Ángel
  • Shin, GiWon
  • Ji, Hanlee
  • Hitchins, Megan
  • Capellá, Gabriel
  • Pasquali, Lorenzo
  • Pineda, Marta
Background: Lynch syndrome (LS), characterised by an increased risk for cancer, is mainly caused by germline pathogenic variants affecting a mismatch repair gene (MLH1, MSH2, MSH6, PMS2). Occasionally, LS may be caused by constitutional MLH1 epimutation (CME) characterised by soma-wide methylation of one allele of the MLH1 promoter. Most of these are "primary" epimutations, arising de novo without any apparent underlying cis-genetic cause, and are reversible between generations. We aimed to characterise genetic and gene regulatory changes associated with primary CME to elucidate possible underlying molecular mechanisms. Methods: Four carriers of a primary CME and three non-methylated relatives carrying the same genetic haplotype were included. Genetic alterations were sought using linked-read WGS in blood DNA. Transcriptome (RNA-seq), chromatin landscape (ATAC-seq, H3K27ac CUT&Tag) and 3D chromatin interactions (UMI-4C) were studied in lymphoblastoid cell lines. The MLH1 promoter SNP (c.-93G > A, rs1800734) was used as a reporter in heterozygotes to assess allele-specific chromatin conformation states. Results: MLH1 epimutant alleles presented a closed chromatin conformation and decreased levels of H3K27ac, as compared to the unmethylated allele. Moreover, the epimutant MLH1 promoter exhibited differential 3D chromatin contacts, including lost and gained interactions with distal regulatory elements. Of note, rare genetic alterations potentially affecting transcription factor binding sites were found in the promoter-contacting region of CME carriers. Conclusions: Primary CMEs present allele-specific differential interaction patterns with neighbouring genes and regulatory elements. The role of the identified cis-regulatory regions in the molecular mechanism underlying the origin and maintenance of CME requires further investigation., This study was supported by the National Institute of Health/National Cancer Institute (R01CA218342), the Spanish Ministry of Science and Innovation, which is part of Agencia Estatal de Investigación (AEI), through the Retos Investigación grants (SAF2015-68016-R, PID2019-111254RB-I00, PID2020-117099RB-I00, PID2023-151585OB-I00, and SAF2017-86242-R), CIBERONC (CB16/12/00234), and the Secretariat for Universities and Research of the Department of Business and Knowledge of the Generalitat de Catalunya grant to support the activities of research groups (2021 SGR 01112). We also thank the CERCA Program/Generalitat de Catalunya for institutional support. M.R.-R. is supported by the IMPULSO Talento Joven grant from DiabetesCERO and the EFSD/Lilly Young Investigator Award.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Wnt genes in colonic polyposis predisposition

  • Quintana, Isabel
  • Tonda, Raúl
  • Parra Farré, Genís
  • Piscia, Davide
  • Beltran, Sergi
  • Valle, Laura
This research was funded by the Spanish Ministry of Science and Innovation (Agencia Estatal de Investigación), and co-funded by FEDER funds a way to build Europe [Grants No. SAF2016-80888-R (LV), PID2020-112595RB-I00 (LV), and PID2019-111254RB-I00 (GC), and predoctoral fellowship “Formación de Personal Investigador” (IQ)]; Instituto de Salud Carlos III [CIBERONC CB16/12/00234, Sara Borrell Postdoctoral contract (PM)]; Government of Catalonia, Spain [PERIS MedPerCan, AGAUR 2017SGR1282, CERCA Program for institutional support]; Scientific Foundation “Asociación Española Contra el Cáncer” [AECC Investigador (MT)]; Marie Skłodowska-Curie Individual Fellowship [Organ-VIP; Grant agreement No. 897064 (NG-A)]. The Solve-RD project is funded by the European Union's Horizon 2020 research and innovation program under grant agreement No. 779257. This study was supported by the European Reference Network on Genetic Tumor Risk Syndromes (ERN GENTURIS) - Project ID No. 739547 (www.genturis.eu), and the COST action CA17118, supported by COST (European Cooperation in Science and Technology).
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Wnt genes in colonic polyposis predisposition

  • Quintana, Isabel
  • Tonda, Raúl
  • Parra Farré, Genís
  • Piscia, Davide
  • Beltran, Sergi
  • Valle, Laura
This research was funded by the Spanish Ministry of Science and Innovation (Agencia Estatal de Investigación), and co-funded by FEDER funds a way to build Europe [Grants No. SAF2016-80888-R (LV), PID2020-112595RB-I00 (LV), and PID2019-111254RB-I00 (GC), and predoctoral fellowship “Formación de Personal Investigador” (IQ)]; Instituto de Salud Carlos III [CIBERONC CB16/12/00234, Sara Borrell Postdoctoral contract (PM)]; Government of Catalonia, Spain [PERIS MedPerCan, AGAUR 2017SGR1282, CERCA Program for institutional support]; Scientific Foundation “Asociación Española Contra el Cáncer” [AECC Investigador (MT)]; Marie Skłodowska-Curie Individual Fellowship [Organ-VIP; Grant agreement No. 897064 (NG-A)]. The Solve-RD project is funded by the European Union's Horizon 2020 research and innovation program under grant agreement No. 779257. This study was supported by the European Reference Network on Genetic Tumor Risk Syndromes (ERN GENTURIS) - Project ID No. 739547 (www.genturis.eu), and the COST action CA17118, supported by COST (European Cooperation in Science and Technology).
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Altered chromatin landscape and 3D interactions associated with primary constitutional MLH1 epimutations

  • Climent-Cantó, Paula
  • Subirana-Granés, Marc
  • Ramos-Rodríguez, Mireia
  • Dámaso, Estela
  • Marín, Fátima
  • Vara, Covadonga
  • Pérez-González, Beatriz
  • Raurell Vila, Helena
  • Munté, Elisabet
  • Soto, José Luis
  • Alonso, Ángel
  • Shin, GiWon
  • Ji, Hanlee
  • Hitchins, Megan
  • Capellá, Gabriel
  • Pasquali, Lorenzo
  • Pineda, Marta
Background: Lynch syndrome (LS), characterised by an increased risk for cancer, is mainly caused by germline pathogenic variants affecting a mismatch repair gene (MLH1, MSH2, MSH6, PMS2). Occasionally, LS may be caused by constitutional MLH1 epimutation (CME) characterised by soma-wide methylation of one allele of the MLH1 promoter. Most of these are "primary" epimutations, arising de novo without any apparent underlying cis-genetic cause, and are reversible between generations. We aimed to characterise genetic and gene regulatory changes associated with primary CME to elucidate possible underlying molecular mechanisms. Methods: Four carriers of a primary CME and three non-methylated relatives carrying the same genetic haplotype were included. Genetic alterations were sought using linked-read WGS in blood DNA. Transcriptome (RNA-seq), chromatin landscape (ATAC-seq, H3K27ac CUT&Tag) and 3D chromatin interactions (UMI-4C) were studied in lymphoblastoid cell lines. The MLH1 promoter SNP (c.-93G > A, rs1800734) was used as a reporter in heterozygotes to assess allele-specific chromatin conformation states. Results: MLH1 epimutant alleles presented a closed chromatin conformation and decreased levels of H3K27ac, as compared to the unmethylated allele. Moreover, the epimutant MLH1 promoter exhibited differential 3D chromatin contacts, including lost and gained interactions with distal regulatory elements. Of note, rare genetic alterations potentially affecting transcription factor binding sites were found in the promoter-contacting region of CME carriers. Conclusions: Primary CMEs present allele-specific differential interaction patterns with neighbouring genes and regulatory elements. The role of the identified cis-regulatory regions in the molecular mechanism underlying the origin and maintenance of CME requires further investigation., This study was supported by the National Institute of Health/National Cancer Institute (R01CA218342), the Spanish Ministry of Science and Innovation, which is part of Agencia Estatal de Investigación (AEI), through the Retos Investigación grants (SAF2015-68016-R, PID2019-111254RB-I00, PID2020-117099RB-I00, PID2023-151585OB-I00, and SAF2017-86242-R), CIBERONC (CB16/12/00234), and the Secretariat for Universities and Research of the Department of Business and Knowledge of the Generalitat de Catalunya grant to support the activities of research groups (2021 SGR 01112). We also thank the CERCA Program/Generalitat de Catalunya for institutional support. M.R.-R. is supported by the IMPULSO Talento Joven grant from DiabetesCERO and the EFSD/Lilly Young Investigator Award.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

The challenge of diagnosing constitutional mismatch repair deficiency syndrome in brain malignancies from young individuals

  • Carrato, Cristina|||0000-0002-1953-8287
  • Sanz, Carolina|||0009-0001-9228-755X
  • Muñoz-Mármol, Ana Maria|||0000-0003-1008-7763
  • Blanco Guillermo, Ignacio|||0000-0002-7414-7481
  • Pineda, Marta|||0000-0002-5403-5845
  • Del Valle, Jesús|||0000-0003-3607-7045
  • Dámaso, Estela|||0000-0002-9650-7791
  • Esteller, M|||0000-0003-4490-6093
  • Musulén, Eva|||0000-0002-9667-6464
Biallelic germline mismatch repair (MMR) gene (MLH1, MSH2, MSH6, and PMS2) mutations are an extremely rare event that causes constitutional mismatch repair deficiency (CMMRD) syndrome. CMMRD is underdiagnosed and often debuts with pediatric malignant brain tumors. A high degree of clinical awareness of the CMMRD phenotype is needed to identify new cases. Immunohistochemical (IHC) assessment of MMR protein expression and analysis of microsatellite instability (MSI) are the first tools with which to initiate the study of this syndrome in solid malignancies. MMR IHC shows a hallmark pattern with absence of staining in both neoplastic and non-neoplastic cells for the biallelic mutated gene. However, MSI often fails in brain malignancies. The aim of this report is to draw attention to the peculiar IHC profile that characterizes CMMRD syndrome and to review the difficulties in reaching an accurate diagnosis by describing the case of two siblings with biallelic MSH6 germline mutations and brain tumors. Given the difficulties involved in early diagnosis of CMMRD we propose the use of the IHC of MMR proteins in all malignant brain tumors diagnosed in individuals younger than 25 years-old to facilitate the diagnosis of CMMRD and to select those neoplasms that will benefit from immunotherapy treatment.
Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
Publicación Artículo científico (JournalArticle)

Altered chromatin landscape and 3D interactions associated with primary constitutional MLH1 epimutations

  • Climent-Cantó, Paula
  • Subirana Granés, Marc
  • Ramos-Rodríguez, Mireia
  • Dámaso, Estela
  • Marín, Fátima
  • Vara, Covadonga
  • Pérez-González, Beatriz
  • Raurell, Helena
  • Munté, Elisabeth
  • Soto, José Luis
  • Alonso Sánchez, Ángel Miguel
  • Shin, GiWon
  • Ji, Hanlee
  • Hitchins, Megan
  • Capellá, Gabriel
  • Pasquali, Lorenzo
  • Pineda, Marta
Background: Lynch syndrome (LS), characterised by an increased risk for cancer, is mainly caused by germline pathogenic variants affecting a mismatch repair gene (MLH1, MSH2, MSH6, PMS2). Occasionally, LS may be caused by constitutional MLH1 epimutation (CME) characterised by soma-wide methylation of one allele of the MLH1 promoter. Most of these are "primary" epimutations, arising de novo without any apparent underlying cis-genetic cause, and are reversible between generations. We aimed to characterise genetic and gene regulatory changes associated with primary CME to elucidate possible underlying molecular mechanisms. Methods: Four carriers of a primary CME and three non-methylated relatives carrying the same genetic haplotype were included. Genetic alterations were sought using linked-read WGS in blood DNA. Transcriptome (RNA-seq), chromatin landscape (ATAC-seq, H3K27ac CUT&Tag) and 3D chromatin interactions (UMI-4C) were studied in lymphoblastoid cell lines. The MLH1 promoter SNP (c.-93G > A, rs1800734) was used as a reporter in heterozygotes to assess allele-specific chromatin conformation states. Results: MLH1 epimutant alleles presented a closed chromatin conformation and decreased levels of H3K27ac, as compared to the unmethylated allele. Moreover, the epimutant MLH1 promoter exhibited differential 3D chromatin contacts, including lost and gained interactions with distal regulatory elements. Of note, rare genetic alterations potentially affecting transcription factor binding sites were found in the promoter-contacting region of CME carriers. Conclusions: Primary CMEs present allele-specific differential interaction patterns with neighbouring genes and regulatory elements. The role of the identified cis-regulatory regions in the molecular mechanism underlying the origin and maintenance of CME requires further investigation., This study was supported by the National Institute of Health/National Cancer Institute (R01CA218342), the Spanish Ministry of Science and Innovation, which is part of Agencia Estatal de Investigación (AEI), through the Retos Investigación grants (SAF2015-68016-R, PID2019-111254RB-I00, PID2020-117099RB-I00, PID2023-151585OB-I00, and SAF2017-86242-R), CIBERONC (CB16/12/00234), and the Secretariat for Universities and Research of the Department of Business and Knowledge of the Generalitat de Catalunya grant to support the activities of research groups (2021 SGR 01112). M.R.-R. is supported by the IMPULSO Talento Joven grant from DiabetesCERO and the EFSD/Lilly Young Investigator Award.